PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.\', \'Hygiene Department, Bari Policlinico General Hospital, Bari, Italy.\', \'Hospital Direction, Bari Policlinico General Hospital, Bari, Italy.\', \'Pharmacy Department, Bari Policlinico General Hospital, Bari, Italy.\', \'Interdisciplinary Department of Medicine, Aldo Moro University of Bari, Bari, Italy.\', \'Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy. Electronic address: silvio.tafuri@uniba.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(22)00124-410.1016/j.vaccine.2022.02.002
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35190212
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all